It revealed that expression levels of HSPD1 mRNA (p = 0.007), MMP14 mRNA (p = 0.015), miR-6881-5p miRNA (p = 0.046) and lncRNA lnc-SPARCL1-1:2 (p = 0.006) were independent predictors of NASH, and NAFLD scoring steatosis grading and fibrosis scoring (p = 0.04) (Table 3). The gene discussed is SPARCL1; the disease is metabolic dysfunction-associated steatohepatitis.